TNFSF15
Tumor necrosis factor ligand superfamily member 15
Also known as: MGC129934, MGC129935, TL1, TL1A, TNF15_HUMAN, VEGI, VEGI192A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95150
- Gene
- TNFSF15
- Ensembl
- ENSG00000181634
- Chromosome
- 9
- Canonical length
- 251 aa
- Protein class
- Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Nuclear membrane,Cytosol
- Secretome location
- Secreted to blood
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein is abundantly expressed in endothelial cells, but is not expressed in either B or T cells. The expression of this protein is inducible by TNF and IL-1 alpha. This cytokine is a ligand for receptor TNFRSF25 and decoy receptor TNFRSF21/DR6. It can activate NF-kappaB and MAP kinases, and acts as an autocrine factor to induce apoptosis in endothelial cells. This cytokine is also found to inhibit endothelial cell proliferation, and thus may function as an angiogenesis inhibitor. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
251 residues, UniProt reviewed canonical sequence.
>O95150|TNFSF15
1 MAEDLGLSFG ETASVEMLPE HGSCRPKARS SSARWALTCC LVLLPFLAGL TTYLLVSQLR
61 AQGEACVQFQ ALKGQEFAPS HQQVYAPLRA DGDKPRAHLT VVRQTPTQHF KNQFPALHWE
121 HELGLAFTKN RMNYTNKFLL IPESGDYFIY SQVTFRGMTS ECSEIRQAGR PNKPDSITVV
181 ITKVTDSYPE PTQLLMGTKS VCEVGSNWFQ PIYLGAMFSL QEGDKLMVNV SDISLVDYTK
241 EDKTFFGAFL LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNFSF15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 8.9 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 8.9 nTPM
- salivary gland: 5.3 nTPM
- urinary bladder: 4.4 nTPM
- placenta: 4.1 nTPM
- lung: 3.9 nTPM
- prostate: 3.8 nTPM
Single-cell type
- prostatic club cells: 74 nCPM
- endometrial glandular cells: 66 nCPM
- epididymal basal cells: 49 nCPM
- prostatic hillock cells: 40 nCPM
- alveolar cells type 2: 31 nCPM
- colonocytes: 30 nCPM
Immune cell
- myeloid DC: 0.6 nTPM
- classical monocyte: 0.4 nTPM
- intermediate monocyte: 0.4 nTPM
- plasmacytoid DC: 0.3 nTPM
- neutrophil: 0.2 nTPM
- basophil: 0.1 nTPM
Brain region
- cerebral cortex: 1.6 nTPM
- white matter: 1.3 nTPM
- medulla oblongata: 1.2 nTPM
- hypothalamus: 1 nTPM
- pons: 1 nTPM
- thalamus: 1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.54
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation of NF-kappaB-inducing kinase activity
- cell surface receptor signaling pathway
- immune response
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of extrinsic apoptotic signaling pathway
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNFSF15 as an antibody target. Whether an autoantibody or antibody against TNFSF15 could matter depends on whether native TNFSF15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNFSF15 is annotated as secreted, so native TNFSF15 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label TNFSF15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...